UPDATE 2-U.S. FDA approves first two-drug HIV regimen in win for GSK
November 22, 2017 at 03:46 AM EST
* Two-drug approach differentiates GSK from Gilead (Adds context on GSK drive to improve pharma sales)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|